Eveline Bezerra

Mrs. Eveline Bezerra


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2011 in Physical Chemistry Chemical Physics
Verified
Journal Article
Closed access
PDF file
RCRoner Ferreira da Costa
Roner Ferreira da Costa
VFValder N. Freire
Valder N. Freire
EBEveline Bezerra
Eveline Bezerra
BCBenildo Cavada
Benildo Cavada
ECEwerton Caetano
Ewerton Caetano
EAEudenilson L. Albuquerque
Eudenilson L. Albuquerque
By taking advantage of the crystallographic data of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) complexed with statins, a quantum biochemistry study based on the density functional theory is performed to estimate the interaction energy for each statin when one considers binding pockets of different sizes. Assuming a correlation between statin potency and the strength of the total HMGR–statin binding energy, clinical data as well as IC50 values of these cholesterol-lowering drugs are successfully explained only after stabilization of the calculated total binding energy for a larger size of the ligand-interacting HGMR region, one with a radius of at least 12.0 Å. Actually, the binding pocket radius suggested by classic works, which was based solely on the interpretation of crystallographic data of the HMGR–statin complex, is smaller than that necessary to achieve total binding energy convergence in our simulations. Atorvastatin and rosuvastatin are shown to be the most strongly bound HMGR inhibitors, while simvastatin and fluvastatin are the weakest ones. A binding site, interaction energy between residues and statin atoms, and residues domain (BIRD) panel is constructed, indicating clear quantum biochemistry-based routes for the development of new statin derivatives.

2 June 2015 in RSC Advances
Verified
Journal Article
Closed access
PDF file
DDDiego Dantas
Diego Dantas
JOJonas I. N. Oliveira
Jonas I. N. Oliveira
JNJosé X. Lima Neto
José X. Lima Neto
RCRoner Ferreira da Costa
Roner Ferreira da Costa
EBEveline Bezerra
Eveline Bezerra
EAEudenilson L. Albuquerque
Eudenilson L. Albuquerque
The total interaction energies of the ibuprofen complexed with FA3/FA4 and FA6 binding sites of human serum albumin are in agreement with the hypothesis that the Sudlow's site II is the main binding pocket for ibuprofen.

2 September 2014 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
Geancarlo ZanattaGeancarlo Zanatta
Geancarlo Zanatta
Gustavo Della-Flora NunesGustavo Della-Flora Nunes
Gustavo Della-Flora Nunes
EBEveline Bezerra
Eveline Bezerra
RCRoner Ferreira da Costa
Roner Ferreira da Costa
AMAlice Martins
Alice Martins
CGCarmem Gottfried
Carmem Gottfried

13 April 2015 in Physical Chemistry Chemical Physics
Verified
Journal Article
Closed access
PDF file
JNJosé X. Lima Neto
José X. Lima Neto
UFUmberto Laino Fulco
Umberto Laino Fulco
EAEudenilson L. Albuquerque
Eudenilson L. Albuquerque
GCGilberto Corso
Gilberto Corso
EBEveline Bezerra
Eveline Bezerra
VFValder N. Freire
Valder N. Freire
We employ quantum biochemistry methods based on the Density Functional Theory (DFT) approach to unveil detailed binding energy features of willardiines co-crystallized with the AMPA receptor.

19 December 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EAErika Costa de Alvarenga
Erika Costa de Alvarenga
MFMatheus Fonseca
Matheus Fonseca
CCClarissa Coelho Carvalho
Clarissa Coelho Carvalho
RFRodrigo Machado Florentino
Rodrigo Machado Florentino
AFAndressa França
Andressa França
MLMaria De Fatima Leite
Maria De Fatima Leite
The angiotensin-I converting enzyme (ACE) plays a central role in the renin-angiotensin system, acting by converting the hormone angiotensin-I to the active peptide angiotensin-II (Ang-II). More recently, ACE was shown to act as a receptor for Ang-II, and its expression level was demonstrated to be higher in melanoma cells compared to their normal counterparts. However, the function that ACE plays as an Ang-II receptor in melanoma cells has not been defined yet. Therefore, our aim was to examine the role of ACE in tumor cell proliferation and migration. We found that upon binding to ACE, Ang-II internalizes with a faster onset compared to the binding of Ang-II to its classical AT1 receptor. We also found that the complex Ang-II/ACE translocates to the nucleus, through a clathrin-mediated process, triggering a transient nuclear Ca2+ signal. In silico studies revealed a possible interaction site between ACE and phospholipase C (PLC), and experimental results in CHO cells, demonstrated that the β3 isoform of PLC is the one involved in the Ca2+ signals induced by Ang-II/ACE interaction. Further studies in melanoma cells (TM-5) showed that Ang-II induced cell proliferation through ACE activation, an event that could be inhibited either by ACE inhibitor (Lisinopril) or by the silencing of ACE. In addition, we found that stimulation of ACE by Ang-II caused the melanoma cells to migrate, at least in part due to decreased vinculin expression, a focal adhesion structural protein. ACE activation regulates melanoma cell proliferation and migration.

12 April 2018 in Parasitology
Verified
Journal Article
Closed access
PDF file
LTLouise Donadello Tessarolo
Louise Donadello Tessarolo
Ramon Róseo Paula Pessoa Bezerra de MenezesRamon Róseo Paula Pessoa Bezerra de Menezes
Ramon Róseo Paula Pessoa Bezerra de Menezes
CMClarissa Perdigão Mello
Clarissa Perdigão Mello
DLDânya Bandeira Lima
Dânya Bandeira Lima
EMEmanuel Paula Magalhães
Emanuel Paula Magalhães
AMAlice Maria Costa Martins
Alice Maria Costa Martins
Chagas disease is a public health problem, affecting about 7 million people worldwide. Benznidazole (BZN) is the main treatment option, but it has limited effectiveness and can cause severe adverse effects. Drug delivery through nanoparticles has attracted the interest of the scientific community aiming to improve therapeutic options. The aim of this study was to evaluate the cytotoxicity of benznidazole-loaded calcium carbonate nanoparticles (BZN@CaCO3) on Trypanosoma cruzi strain Y. It was observed that BZN@CaCO3 was able to reduce the viability of epimastigote, trypomastigote and amastigote forms of T. cruzi with greater potency when compared with BZN. The amount of BZN necessary to obtain the same effect was up to 25 times smaller when loaded with CaCO3 nanoparticles. Also, it was observed that BZN@CaCO3 enhanced the selectivity index. Furthermore, the cell-death mechanism induced by both BZN and BZN@CaCO3 was evaluated, indicating that both substances caused necrosis and changed mitochondrial membrane potential.